Results 221 to 230 of about 23,252 (243)

Prevalence and Correlates of Adynamic Bone Disease in Patients with Kidney Failure in Singapore. [PDF]

J Clin Med
Shuit SK, Wee EYQ, Teh YK, Chen F, Lim RS, Bairy M.   +5 more
europepmc   +1 more source

Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

JAMA Intern Med, 2019
Spoendlin J, Paik JM, Tsacogianis T, Kim SC, Schneeweiss S, Desai RJ.   +5 more
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Engineered B7-H3 Binding in Modular Gp2 Miniproteins. [PDF]

Biotechnol Bioeng
Harthorn A, Windsor HK, Schmitz Z, Cheung N, Agwaramgbo E, Hackel BJ.   +5 more
europepmc   +1 more source

Oral phosphate binders

Kidney International, 2009
Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and is present in the majority of dialysis patients. Hyperphosphatemia is observationally and statistically associated with increased cardiovascular mortality among ...
Alastair J Hutchison
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Effects of phosphate binders on bone biomarkers and bone density in haemodialysis patients

Nephrology, 2022
Suwasin Udomkarnjananun, Jeerath Phannajit, Kullaya Takkavatakarn   +2 more
exaly  

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

Lancet, The, 2013
Sophie A Jamal, Ben Vandermeer, Paolo Raggi   +2 more
exaly  

Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials

American Journal of Kidney Diseases, 2009
Suetonia C Palmer, Jonathan C Craig, Grahame J Elder   +2 more
exaly